Audentes Therapeutics, Inc. 4
4 · Audentes Therapeutics, Inc. · Filed Jan 27, 2017
Insider Transaction Report
Form 4
GRAY JOHN T.
Senior Vice President, R & D
Transactions
- Award
Stock Option (right to buy)
2017-01-25+70,000→ 70,000 totalExercise: $15.26Exp: 2027-01-25→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]The option vests as to 2.0833% of the total shares monthly, beginning February 25, 2017, with 100% of the total shares vested and exercisable on January 25, 2021, subject to the reporting person's provision of service to the issuer on each vesting date.